This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 75
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study assessed the efficacy, safety, and pharmacokinetics of indacaterol salts (maleate, xinafoate and acetate) in patients with asthma.

Provided treatments

  • Drug: Indacaterol maleate 400 μg
  • Drug: Indacaterol acetate 400 μg
  • Drug: Indacaterol xinafoate 400 μg
  • Drug: Placebo to indacaterol
Tris trial is registered with FDA with number: NCT00927901. The sponsor of the trial is Novartis Pharmaceuticals and it is looking for 30 volunteers for the current phase.
Official trial title:
A Multi-centre, Randomized, Double-blind, Placebo-controlled, Multiple-dose, 4-way Crossover Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Orally Inhaled Indacaterol Salts (Maleate, Xinafoate, and Acetate) in Patients With Persistent Asthma